263 related articles for article (PubMed ID: 18463419)
1. Inhibition of MCP-1/CCR2 signaling does not inhibit intimal proliferation in a mouse aortic transplant model.
Alexis JD; Pyo RT; Chereshnev I; Katz J; Rollins BJ; Charo IF; Taubman MB
J Vasc Res; 2008; 45(6):538-46. PubMed ID: 18463419
[TBL] [Abstract][Full Text] [Related]
2. Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy.
Saiura A; Sata M; Hiasa K; Kitamoto S; Washida M; Egashira K; Nagai R; Makuuchi M
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1886-90. PubMed ID: 15284091
[TBL] [Abstract][Full Text] [Related]
3. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
4. Turn-over of meningeal and perivascular macrophages in the brain of MCP-1-, CCR-2- or double knockout mice.
Schilling M; Strecker JK; Ringelstein EB; Kiefer R; Schäbitz WR
Exp Neurol; 2009 Oct; 219(2):583-5. PubMed ID: 19615366
[TBL] [Abstract][Full Text] [Related]
5. Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2.
Koth LL; Rodriguez MW; Bernstein XL; Chan S; Huang X; Charo IF; Rollins BJ; Erle DJ
Respir Res; 2004 Sep; 5(1):12. PubMed ID: 15377395
[TBL] [Abstract][Full Text] [Related]
6. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2.
Heil M; Ziegelhoeffer T; Wagner S; Fernández B; Helisch A; Martin S; Tribulova S; Kuziel WA; Bachmann G; Schaper W
Circ Res; 2004 Mar; 94(5):671-7. PubMed ID: 14963007
[TBL] [Abstract][Full Text] [Related]
7. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy.
Frangogiannis NG; Dewald O; Xia Y; Ren G; Haudek S; Leucker T; Kraemer D; Taffet G; Rollins BJ; Entman ML
Circulation; 2007 Feb; 115(5):584-92. PubMed ID: 17283277
[TBL] [Abstract][Full Text] [Related]
8. Monocyte chemoattractant protein-1 or macrophage inflammatory protein-1alpha deficiency does not affect angiotensin II-induced intimal hyperplasia in carotid artery ligation model.
Zhang LN; da Cunha V; Martin-McNulty B; Rutledge J; Vergona R; Sullivan ME; Wang YX
Cardiovasc Pathol; 2007; 16(4):231-6. PubMed ID: 17637431
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
10. Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo.
Schepers A; Eefting D; Bonta PI; Grimbergen JM; de Vries MR; van Weel V; de Vries CJ; Egashira K; van Bockel JH; Quax PH
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2063-9. PubMed ID: 16825596
[TBL] [Abstract][Full Text] [Related]
11. Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation.
Feinberg MW; Shimizu K; Lebedeva M; Haspel R; Takayama K; Chen Z; Frederick JP; Wang XF; Simon DI; Libby P; Mitchell RN; Jain MK
Circ Res; 2004 Mar; 94(5):601-8. PubMed ID: 14752027
[TBL] [Abstract][Full Text] [Related]
12. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.
Dai E; Liu LY; Wang H; McIvor D; Sun YM; Macaulay C; King E; Munuswamy-Ramanujam G; Bartee MY; Williams J; Davids J; Charo I; McFadden G; Esko JD; Lucas AR
PLoS One; 2010 May; 5(5):e10510. PubMed ID: 20463901
[TBL] [Abstract][Full Text] [Related]
14. Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse.
Dambach DM; Watson LM; Gray KR; Durham SK; Laskin DL
Hepatology; 2002 May; 35(5):1093-103. PubMed ID: 11981759
[TBL] [Abstract][Full Text] [Related]
15. Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function.
Spinetti G; Wang M; Monticone R; Zhang J; Zhao D; Lakatta EG
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1397-402. PubMed ID: 15178559
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
[TBL] [Abstract][Full Text] [Related]
17. Monocyte recruitment and myelin removal are delayed following spinal cord injury in mice with CCR2 chemokine receptor deletion.
Ma M; Wei T; Boring L; Charo IF; Ransohoff RM; Jakeman LB
J Neurosci Res; 2002 Jun; 68(6):691-702. PubMed ID: 12111830
[TBL] [Abstract][Full Text] [Related]
18. CCL2-independent role of CCR2 in immune responses against Leishmania major.
Quinones MP; Estrada CA; Jimenez F; Martinez H; Willmon O; Kuziel WA; Ahuja SK; Ahuja SS
Parasite Immunol; 2007 Apr; 29(4):211-7. PubMed ID: 17371458
[TBL] [Abstract][Full Text] [Related]
19. CCR2 deficiency decreases intimal hyperplasia after arterial injury.
Roque M; Kim WJ; Gazdoin M; Malik A; Reis ED; Fallon JT; Badimon JJ; Charo IF; Taubman MB
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):554-9. PubMed ID: 11950690
[TBL] [Abstract][Full Text] [Related]
20. MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury.
Kim WJ; Chereshnev I; Gazdoiu M; Fallon JT; Rollins BJ; Taubman MB
Biochem Biophys Res Commun; 2003 Oct; 310(3):936-42. PubMed ID: 14550294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
